Test Bank For Advanced Pharmacology for Prescribers 1st Edition by Brent Q. Luu, Gerald Kayingo, Virginia McCoy Hass

Test Bank:
2w




Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
2w 2w 2w 2w 2w 2w 2w 2w




2w Edition, 2024
2w

, Table of Contents 2w 2w




Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines .............................................. 3
2 w 2 w 2w 2 w 2w 2w 2 w 2 w




Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................... 13
2 w 2w 2 w 2 w




Chapter4: Pharmacogenetics and Pharmacogenomics................................................................................ 25
2w 2 w 2w




Chapter 5: Pharmacology Across the Life Span.......................................................................................... 30
2 w 2w 2w 2w 2w 2w




Chapter 6: Drug-Therapy Prescribing in Special Populations ..................................................................... 36
2 w 2w 2w 2w 2w 2w




Chapter 7: Drug Development and Approval ............................................................................................. 45
2 w 2w 2w 2 w 2w




Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-Substance
2w 2w 2w 2w 2w 2w 2w 2w 2w




Prescribing Chapter 10: Antibiotic Stewardship .......................................................................................... 51
2w 2w 2w 2w 2w




Chapter 11: Applied Calculations for Prescribing ...................................................................................... 58
2 w 2w 2w 2 w 2 w




Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-Focused
2w 2w 2w 2w 2w 2w 2w 2w 2w




Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter 14:
2w 2w 2w 2w 2w 2w 2w 2w 2w 2w 2w 2w




Pharmacotherapy for Eye Conditions ......................................................................................................... 67
2w 2w 2w 2w




Chapter 15: Pharmacotherapy for Skin Conditions .................................................................................... 74
2 w 2w 2w 2 w 2w




Chapter 16: Pharmacotherapy for Neurologic Conditions ......................................................................... 81
2 w 2w 2w 2 w 2 w




Chapter 17: Pharmacotherapy for Cardiovascular Conditions................................................................... 94
2 w 2w 2 w 2 w 2 w




Chapter 18: Pharmacotherapy for Respiratory Conditions .......................................................................106
2 w 2w 2 w 2 w 2 w




Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Support
2w 2w 2w 2w 2w 2w 2w 2w 2w




.................................................................................................................................................................117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ....................................................................128
2 w 2w 2w 2 w 2w




Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders.............................133
2w 2w 2w 2 w 2w 2 w 2w 2w 2w




Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ................................146
2 w 2w 2 w 2 w 2 w 2 w 2 w




Chapter 23: Therapeutic Applications of Immunology and Vaccines ......................................................158
2 w 2w 2 w 2 w 2w 2 w 2 w




Chapter 24: Pharmacotherapy for Endocrine Disorders ............................................................................163
2 w 2w 2w 2 w 2w




Chapter 25: Pharmacotherapy for Hematologic Disorders ........................................................................174
2 w 2w 2w 2w 2 w




Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ......................................190
2 w 2w 2w 2w 2 w 2w 2 w 2w




Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ...................................................196
2 w 2w 2 w 2 w 2 w 2 w 2 w




Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .........................................................211
2 w 2 w 2 w 2 w 2w 2 w 2 w




Chapter 29: Pharmacotherapy Related to Transgender Care.....................................................................217
2 w 2w 2 w 2 w 2w 2 w




Chapter 30: Antimicrobial Pharmacotherapy ............................................................................................224
2 w 2w 2 w




Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................235
2 w 2w 2 w




Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and
2w 2w 2w 2w 2w 2w 2w 2w 2w




NeurocognitiveConditions .......................................................................................................................247
2w 2w




Chapter 33: Pharmacotherapy for Pain Management ................................................................................257
2 w 2w 2w 2 w 2w




Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ...........................................267
2 w 2w 2 w 2w 2 w 2w 2w 2w 2w




Chapter 35: Over-the-Counter Medications ..............................................................................................283
2 w 2w 2 w




Chapter 36: Pharmacotherapy for Obesity ................................................................................................291
2 w 2w 2w 2 w

,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
2w 2w 2w 2w 2w 2w 2w 2w




MULTIPLE CHOICE 2w




• What is the primary purpose of the nursing assessment?
2w 2w 2w 2w 2 w 2w 2 w 2 w




A. Identifying underlying pathologic conditions 2 w 2 w 2 w




B. Assisting the physician in identifying medical conditions 2 w 2 w 2 w 2w 2 w 2 w




C. Determining the patients mental status 2 w 2 w 2w 2w




D. Exploring patient responses to health problems 2 w 2 w 2 w 2 w 2 w




ANS: D 2w




A nursing assessment is done to identify the patients response to health
2w 2w 2w 2w 2w 2w 2w 2w 2w 2w 2w




problems. During the nursing assessment phase, a comprehensive
2w 2w 2w 2w 2w 2w 2w 2w




information base is developed through a physical examination, nursing
2w 2w 2w 2w 2w 2w 2w 2w 2w




history, medication history, and professional observation. Identifying
2w 2w 2w 2w 2w 2w 2w




underlying pathologic conditions and assisting the physician in identifying
2w 2w 2w 2w 2w 2w 2w 2w 2w




medical conditions is not part of the nursing process. Determining the patients
2w 2w 2w 2w 2w 2w 2w 2w 2w 2w 2w 2w




2mental status is one part of the nursing assessment, but it is not the
w 2w 2 w 2 w 2w 2 w 2w 2 w 2 w 2 w 2 w 2 w 2 w 2w




primary purpose.
2w 2w




DIF: Cognitive Level: Comprehension
2w 2w 2w




REF: dm 36 OBJ: 1 | 3 TOP: Nursing
2w 2w 2w 2w 2w 2w 2w 2w 2w




Process Step: Assessment
2w 2w 2w




MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
2w 2 w 2 w 2 w 2 w 2w 2 w 2 w




• What is the basis of the NANDA I taxonomy? 2w 2w 2w 2w 2w 2w 2w 2 w




A. Functional health patterns 2 w 2w




B. Human response patterns 2w 2w




C. Basic human needs 2 w 2 w




D. Pathophysiologic needs 2 w




ANS: B 2w




The NANDA I taxonomy identifies human response patterns.
2 w 2 w 2 w 2 w 2 w 2 w 2 w




Functional components of health patterns are limited to activity, fluid
2w 2w 2w 2w 2w 2w 2w 2w 2w 2w




volume, nutrition, self care, and sensory perception. Basic human needs
2w 2w 2w 2w 2w 2w 2w 2w 2w 2w




comprise less than merely health patterns. Pathophysiologic needs are not
2w 2w 2w 2w 2w 2w 2w 2w 2w 2 w




part of the scope of NANDA I.
2w 2w 2w 2w 2w 2w 2w

, DIF: Cognitive Level: Knowledge REF:
2w 2w 2w 2w




pp. 37-38 OBJ: 5 TOP:
2w 2w 2w 2w 2w




Nursing Process Step: Diagnosis 2w 2 w 2w




MSC: NCLEX Client Needs Category: Physiological Integrity
2w 2 w 2 w 2 w 2 w 2 w




• Which task is included in the assessment step of the nursing process?
2w 2w 2w 2 w 2w 2w 2w 2 w 2w 2 w 2 w




A. Establishing patient goals/outcomes 2 w 2 w




B. Implementing the nursing care plan (NCP) 2 w 2 w 2 w 2 w 2 w




C. Measuring goal/outcome achievement 2 w 2 w




D. Collecting and communicating data 2w 2 w 2 w




ANS: D 2w




Data are collected and communicated in the assessment phase of the nursing
2w 2w 2w 2w 2w 2w 2w 2w 2w 2w 2w




process. Establishing goals is the function of planning.
2w 2w 2w 2w 2w 2w 2w 2w




Implementing the NCP is the function of implementation. Measuring 2w 2w 2w 2w 2w 2w 2w 2w




outcome achievement is the function of evaluation.
2w 2w 2w 2w 2w 2w 2w




DIF: Cognitive Level: Comprehension
2w 2w 2w




REF: dm 36 OBJ: 2 | 3 TOP: Nursing
2w 2w 2w 2w 2w 2w 2w 2w 2w




Process Step: Assessment
2w 2w 2w




MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
2w 2 w 2 w 2 w 2 w 2w 2 w 2 w




• Which statement regarding nursing diagnoses is accurate?
2w 2 w 2 w 2 w 2 w 2 w




a. Nursing diagnoses remain the same for as long as the disease is present. 2w 2 w 2w 2w 2 w 2w 2 w 2w 2w 2w 2 w 2 w




b. Nursing diagnoses are written to identify disease states. 2 w 2 w 2 w 2w 2 w 2w 2w




c. Nursing diagnoses describe patient problems that nurses treat. 2 w 2 w 2 w 2 w 2 w 2 w 2 w




d. Nursing diagnoses identify causes related to illness. 2 w 2 w 2w 2 w 2 w 2 w




ANS: C 2w




Diagnostic statements identify problems a nurse is independently able to treat
2w 2w 2w 2w 2w 2w 2w 2w 2w 2w




within the scope of professional practice. Nursing diagnoses vary with the
2w 2w 2w 2w 2w 2w 2w 2w 2w 2w 2w




changing condition of the patient. The response patterns are unique to the
2w 2w 2w 2w 2w 2w 2w 2w 2w 2w 2w 2w




patient and are not disease specific. Nursing diagnoses describe the patients
2w 2w 2w 2w 2w 2w 2w 2w 2w 2w 2w




human response pattern.
2w 2w 2w




DIF: Cognitive Level: Comprehension
2 w 2 w 2 w